General construction pattern of histamine H3-receptor antagonists: Change of a paradigm

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 15, 1998, Pages 2011-2016

  Stark, H ^a   Ligneau, X ^b   Arrang, J M ^c   Schwartz, J C ^c   Schunack, W ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Laboratoire Bioprojet   (France)

^c U de Neurobiologie et Pharmacol M   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBENPROPIT; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; IODOPROXYFAN; THIOPERAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; MOUSE; NONHUMAN; PROTEIN INTERACTION; RAT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; BRAIN; GUINEA PIGS; HISTAMINE ANTAGONISTS; HISTAMINE RELEASE; ILEUM; MICE; RATS; RECEPTORS, HISTAMINE H3; SYNAPTOSOMES;

EID: 0032483065     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00342-4     Document Type: Article

References (18)

1. 1. Hill, S. J.; Ganellin, C. R.; Timmerman, H.; Schwartz, J.-C.; Shankley, N. P.; Young, J. M.; Schunack, W.; Levi, R.; Haas, H. L. Pharmacol. Rev. 1997, 49, 253-278.
2. 2. Stark, H.; Schlicker, E.; Schunack, W. Drugs Future 1996, 21, 507-520.
3. 3. Leurs, R.; Vollinga, R. C.; Timmerman, H. Prog. Drug Res. 1995, 45, 107-165.
4. 4. Onodera, K.; Miyazaki, S.; Imaizumi, M.; Stark, H.; Schunack, W. Naunyn-Schmiedeberg's Arch. Pharmacol., in press.
5. 5. Soe-Jensen, P.; Knigge, U.; Garbarg, M.; Kjaer, A.; Rouleau, A.; Bach, F. W.; Schwartz, J.-C.; Warberg, J. Neuroendocrinology 1993, 57, 532-540.
6. 6. Meguro, K. I.; Yanai, K.; Sakai, N.; Sakurai, E.; Maeyama, K.; Sasaki, H.; Watanabe, T. Pharmacol. Biochem. Behav. 1995, 50, 321-325.
7. 7. Monti, J. M. Life Sci. 1993, 53, 1331-1338.
8. 8. Sellier, C.; Buschauer, A.; Elz, S.; Schunack, W. Liebigs Ann. Chem. 1992, 317-323.
9. 9. Stark, H.; Purand, K.; Ligneau, X.; Rouleau, A.; Arrang, J.-M.; Garbarg, M.; Schwartz, J.-C.; Schunack, W. J. Med. Chem. 1996, 39, 1157-1163.
10. 10. Schwartz, J.-C.; Arrang, J.-M.; Garbarg, M.; Quemener, A.; Lecomte, J.-M.; Ligneau, X.; Schunack, W.; Stark, H.; Purand, K.; Hüls, A.; Reidemeister, S.; Athmani, S.; Ganellin, C. R.; Pelloux-Léon, N.; Tertiuk, W.; Krause, M.; Sadek, B. PCT WO 96/29 315 (03.21.1995).
11. 3).
12. 2).
13. 13. Garbarg, M.; Arrang, J.-M.; Rouleau, A.; Ligneau, X.; Dam Trung Tuong, M.; Schwartz, J.-C.; Ganellin, C. R. J. Pharmacol. Exp. Ther. 1992, 263, 304-310.
14. 14. Ligneau, X.; Garbarg, M.; Vizuete, M. L.; Diaz, J.; Purand, K.; Stark, H.; Schunack, W.; Schwartz, J.-C. J. Pharmacol. Exp. Ther. 1994, 271, 452-459.
15. 15. Stark, H.; Hüls, A.; Ligneau, X.; Arrang, J.-M.; Schwartz, J.-C.; Schunack, W. Pharmazie 1997, 52, 495-500.
16. th Noordwijkerhout-Camerino Symposium, May 11-16, 1997, Noordwijkerhout/The Netherlands.
17. 17. Schwartz, J.-C.; Arrang, J.-M.; Garbarg, M.; Pollard, H.; Ruat, M. Physiol. Rev. 1991, 71, 1-51.
18. 18. Schwartz, J.-C.; Arrang, J.-M., Garbarg, M., Traiffort, E. in Psychopharmacology: The Fourth Generation of Progress. Bloom, F. E.; Kupfer, D. J. (eds.), Raven Press, New York, 1995, pp 397-405.